<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=SERBA-2</id>
	<title>SERBA-2 - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=SERBA-2"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=SERBA-2&amp;action=history"/>
	<updated>2026-04-12T07:10:23Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=SERBA-2&amp;diff=49948&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=SERBA-2&amp;diff=49948&amp;oldid=prev"/>
		<updated>2025-03-18T10:34:16Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:34時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49947:rev-49948 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=SERBA-2&amp;diff=49947&amp;oldid=prev</id>
		<title>bsd&gt;Citation bot: Alter: title. | Use this bot. Report bugs. | Suggested by BrownHairedGirl | #UCB_webform 3091/3837</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=SERBA-2&amp;diff=49947&amp;oldid=prev"/>
		<updated>2022-08-21T06:49:02Z</updated>

		<summary type="html">&lt;p&gt;Alter: title. | &lt;a href=&quot;/w/index.php?title=WP:UCB&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:UCB (存在しないページ)&quot;&gt;Use this bot&lt;/a&gt;. &lt;a href=&quot;/w/index.php?title=WP:DBUG&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:DBUG (存在しないページ)&quot;&gt;Report bugs&lt;/a&gt;. | Suggested by BrownHairedGirl | #UCB_webform 3091/3837&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = &lt;br /&gt;
| Watchedfields = &lt;br /&gt;
| verifiedrevid = &lt;br /&gt;
| IUPAC_name = (3a&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,4&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,9b&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-4-(4-Hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[&amp;#039;&amp;#039;c&amp;#039;&amp;#039;]chromen-8-ol&lt;br /&gt;
| image = SERBA-2.svg&lt;br /&gt;
| width = 250&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = &lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Identifiers --&amp;gt;&lt;br /&gt;
| CAS_number_Ref = &lt;br /&gt;
| CAS_number = 533884-10-5&lt;br /&gt;
| CAS_supplemental = &lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| ATC_supplemental = &lt;br /&gt;
| PubChem = 9925763&lt;br /&gt;
| IUPHAR_ligand = &lt;br /&gt;
| DrugBank_Ref = &lt;br /&gt;
| DrugBank = &lt;br /&gt;
| ChemSpiderID_Ref = &lt;br /&gt;
| ChemSpiderID = 8101398&lt;br /&gt;
| UNII = &lt;br /&gt;
| KEGG = &lt;br /&gt;
| ChEBI = &lt;br /&gt;
| ChEMBL = 216355&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=18 | H=18 | O=3&lt;br /&gt;
| SMILES = C1C[C@@H]2[C@H](C1)C3=C(C=CC(=C3)O)O[C@@H]2C4=CC=C(C=C4)O&lt;br /&gt;
| StdInChI_Ref = &lt;br /&gt;
| StdInChI = 1S/C18H18O3/c19-12-6-4-11(5-7-12)18-15-3-1-2-14(15)16-10-13(20)8-9-17(16)21-18/h4-10,14-15,18-20H,1-3H2/t14-,15+,18+/m0/s1&lt;br /&gt;
| StdInChIKey_Ref = &lt;br /&gt;
| StdInChIKey = XIESSJVMWNJCGZ-HDMKZQKVSA-N&lt;br /&gt;
| synonyms = (2&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,3&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,4&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-SERBA&amp;lt;ref name=&amp;quot;pmid23713677&amp;quot; /&amp;gt;&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;SERBA-2&amp;#039;&amp;#039;&amp;#039;, short for &amp;#039;&amp;#039;&amp;#039;selective estrogen receptor beta agonist-2&amp;#039;&amp;#039;&amp;#039;, is a [[synthetic compound|synthetic]], [[nonsteroidal]] [[estrogen]] which acts as a selective [[ERβ]] [[agonist]].&amp;lt;ref name=&amp;quot;pmid17034120&amp;quot;&amp;gt;{{cite journal | vauthors = Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V | title = Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia | journal = J. Med. Chem. | volume = 49 | issue = 21 | pages = 6155–7 | year = 2006 | pmid = 17034120 | doi = 10.1021/jm060491j }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid19967775&amp;quot;&amp;gt;{{cite journal | vauthors = Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA | title = Estrogen receptor β ligands: recent advances and biomedical applications | journal = Med Res Rev | volume = 31 | issue = 3 | pages = 364–442 | year = 2011 | pmid = 19967775 | doi = 10.1002/med.20186 | s2cid = 3841877 }}&amp;lt;/ref&amp;gt; For the [[ERα]] and ERβ, SERBA-2 has [[affinity (pharmacology)|affinities]] (K&amp;lt;sub&amp;gt;i&amp;lt;/sub&amp;gt;) of 14.5&amp;amp;nbsp;nM and 1.54&amp;amp;nbsp;nM, [[efficacy|efficacies]] of 85% and 100%, and [[EC50|EC&amp;lt;sub&amp;gt;50&amp;lt;/sub&amp;gt;]] values of 85&amp;amp;nbsp;nM and 3.61&amp;amp;nbsp;nM, respectively, demonstrating 9-fold [[binding selectivity]] and 11-fold [[functional selectivity]] for the ERβ over the ERα.&amp;lt;ref name=&amp;quot;pmid17034120&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;pmid19967775&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;pmid20738246&amp;quot;&amp;gt;{{cite journal | vauthors = Lóránd T, Vigh E, Garai J | title = Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens | journal = Curr. Med. Chem. | volume = 17 | issue = 30 | pages = 3542–74 | year = 2010 | pmid = 20738246 | doi = 10.2174/092986710792927813}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid23713677&amp;quot;&amp;gt;{{cite journal | vauthors = Paterni I, Bertini S, Granchi C, Macchia M, Minutolo F | title = Estrogen receptor ligands: a patent review update | journal = Expert Opin Ther Pat | volume = 23 | issue = 10 | pages = 1247–71 | year = 2013 | pmid = 23713677 | doi = 10.1517/13543776.2013.805206 | s2cid = 6259593 }}&amp;lt;/ref&amp;gt; An [[enantiomer]] of SERBA-2, [[erteberel]] (SERBA-1), is more [[potency (pharmacology)|potent]] and selective in comparison and is under development for the treatment of [[schizophrenia]].&amp;lt;ref name=&amp;quot;AdisInsight&amp;quot;&amp;gt;{{cite web |url=https://adisinsight.springer.com/drugs/800031986 |title=Erteberel - AdisInsight |website=adisinsight.springer.com |access-date=15 January 2022 |archive-url=https://web.archive.org/web/20161231170122/https://adisinsight.springer.com/drugs/800031986 |archive-date=31 December 2016 |url-status=dead}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid17034120&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;pmid19967775&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;pmid23713677&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[8β-VE2]]&lt;br /&gt;
* [[Diarylpropionitrile]]&lt;br /&gt;
* [[ERB-196]]&lt;br /&gt;
* [[Prinaberel]]&lt;br /&gt;
* [[WAY-200070]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Benzopyrans]]&lt;br /&gt;
[[Category:Diols]]&lt;br /&gt;
[[Category:Selective ERβ agonists]]&lt;br /&gt;
[[Category:Synthetic estrogens]]&lt;br /&gt;
[[Category:Cyclopentanes]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{genito-urinary-drug-stub}}&lt;/div&gt;</summary>
		<author><name>bsd&gt;Citation bot</name></author>
	</entry>
</feed>